文献速递急性肾损伤慢性肾脏病

急性肾损伤临床与生物标志物数据的联合建模识别出具有不同结局的独特亚表型

Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing Outcomes.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-03-28

研究基于ASSESS-AKI队列中748例AKI患者,对炎症、损伤及修复/健康生物标志物进行层次聚类,识别出4种亚表型。亚表型3和4与亚表型2相比死亡风险更高,调整后风险比分别为2.9(95%CI 1.8-4.6)和1.6(95%CI 1.01-2.6,P=0.04);亚表型3还与慢性肾脏病及心血管事件风险增加三倍独立相关。

要点

  • 基于生物标志物聚类识别出4种AKI亚表型,临床特征与结局不同。
  • 亚表型3死亡风险为亚表型2的2.9倍(95%CI 1.8-4.6)。
  • 亚表型3与慢性肾脏病及心血管事件风险增加三倍独立相关。

核心结论

  • 发现四种AKI亚表型,其临床特征和生物标志物谱不同,并与长期临床结局相关。

研究设计与样本

  • 研究纳入ASSESS-AKI队列中748例AKI患者,采用Ward联接的层次聚类方法对炎症、损伤及修复/健康生物标志物进行分析。
  • 使用Cox比例风险模型评估亚表型与心肾事件及死亡的关联。

主要发现

  • 748例AKI患者中,AKI 1期543例(73%),2期112例(15%),3期93例(12%);平均年龄64(13)岁;男性508例(68%);中位随访4.7(Q1:2.9,Q3:5.7)年。
  • 亚表型1(N=181)肾脏损伤分子(KIM-1)和肌钙蛋白T水平最高;亚表型2(N=250)尿调节素水平最高。
  • 亚表型3(N=159)脑钠肽前体和血浆肿瘤坏死因子受体-1及-2显著升高,KIM-1和中性粒细胞明胶酶相关脂质运载蛋白浓度低。
  • 亚表型4(N=158)以脓毒症相关AKI为主,血管/肾脏炎症标志物(YKL-40、MCP-1)和损伤标志物(中性粒细胞明胶酶相关脂质运载蛋白、KIM-1)水平最高。
  • 与亚表型2相比,亚表型3和4与更高死亡风险独立相关,调整后风险比分别为2.9(95%CI 1.8-4.6)和1.6(95%CI 1.01-2.6,P=0.04)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: AKI is a heterogeneous syndrome. Current subphenotyping approaches have only used limited laboratory data to understand a much more complex condition. METHODS: We focused on patients with AKI from the Assessment, Serial Evaluation, and Subsequent Sequelae in AKI (ASSESS-AKI). We used hierarchical clustering with Ward linkage on biomarkers of inflammation, injury, and repair/health. We then evaluated clinical differences between subphenotypes and examined their associations with cardiorenal events and death using Cox proportional hazard models. RESULTS: We included 748 patients with AKI: 543 (73%) of them had AKI stage 1, 112 (15%) had AKI stage 2, and 93 (12%) had AKI stage 3. The mean age (±SD) was 64 (13) years; 508 (68%) were men; and the median follow-up was 4.7 (Q1: 2.9, Q3: 5.7) years. Patients with AKI subphenotype 1 ( N =181) had the highest kidney injury molecule (KIM-1) and troponin T levels. Subphenotype 2 ( N =250) had the highest levels of uromodulin. AKI subphenotype 3 ( N =159) comprised patients with markedly high pro-brain natriuretic peptide and plasma tumor necrosis factor receptor-1 and -2 and low concentrations of KIM-1 and neutrophil gelatinase-associated lipocalin. Finally, patients with subphenotype 4 ( N =158) predominantly had sepsis-AKI and the highest levels of vascular/kidney inflammation (YKL-40, MCP-1) and injury (neutrophil gelatinase-associated lipocalin, KIM-1). AKI subphenotypes 3 and 4 were independently associated with a higher risk of death compared with subphenotype 2 and had adjusted hazard ratios of 2.9 (95% confidence interval, 1.8 to 4.6) and 1.6 (95% confidence interval, 1.01 to 2.6, P = 0.04), respectively. Subphenotype 3 was also independently associated with a three-fold risk of CKD and cardiovascular events. CONCLUSIONS: We discovered four AKI subphenotypes with differing clinical features and biomarker profiles that are associated with longitudinal clinical outcomes.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Vasquez-Rios G, Oh W, Lee S, et al. Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing Outcomes. Clin J Am Soc Nephrol. 2023. PMID: 36975209. doi:10.2215/CJN.0000000000000156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。